Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of the earliest event reported) May 19, 2011

 

 

SRI/SURGICAL EXPRESS, INC.

(Exact Name of Registrant as specified in Charter)

 

 

 

Florida   001-34953   59-3252632

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

12425 Race Track Road

Tampa, Florida 33626

(Address of Principal Executive Offices)

(813) 891-9550

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Shareholders of SRI/Surgical Express, Inc. (the “Company”) held on May 19, 2011, the shareholders elected James M. Emanuel, Charles W. Federico and Gerald Woodard as directors of the Company to serve until the 2014 Annual Meeting of Shareholders. The final voting results in this election were as follows:

 

Director    Votes For     

Votes Against

or Withheld

     Abstentions     

Broker

Non-Votes

 

James M. Emanuel

     2,598,185         1,852,808         -0-         1,171,130   

Charles W. Federico

     2,598,185         1,852,808         -0-         1,171,130   

Gerald Woodard

     2,605,642         1,845,351         -0-         1,171,130   

James T. Boosales, Michael D. Israel, Charles T. Orsatti and Wayne R. Peterson continue to serve as directors of the Company.

Shareholders also ratified the appointment of Grant Thornton LLP as the Company’s independent auditors. The final voting results were as follows:

 

     Votes For     

Votes

Against

     Abstentions     

Broker

Non-Votes

 

Ratification of Grant Thornton LLP

     5,517,860         101,970         2,293         -0-   


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunder duly authorized.

 

  SRI/SURGICAL EXPRESS, INC.
  (Registrant)
Dated: May 23, 2011   By:  

/s/ Mark R. Faris

    Mark R. Faris
    Chief Financial Officer